Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions

NCT01917682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 754

Last updated 2020-12-22

Study results available
· View outcomes & findings →

Summary

To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.

Conditions

Interventions

PROCEDURE

CorPath-assisted Percutaneous Coronary Intervention

Robotic-assisted Percutaneous Coronary Intervention

Sponsors & Collaborators

  • Corindus Inc.

    lead INDUSTRY

Principal Investigators

  • Giora Weisz, MD · Columbia University Medical Center/New York-Presbyterian Hospital

  • Chris Cain · VP, Clinical Affairs

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917682 on ClinicalTrials.gov